ITPC
  • About
    • Vision, Mission, Values
    • History
    • How We Work
    • Our Regions
    • Our Team
    • Our Board
  • Our Work
    • Treatment Education & Research
    • Intellectual Property & Access to Medicines
    • Community Monitoring
    • Building Activism
  • Our Campaigns
    • Be Healthy – Know Your Viral Load
    • Make Medicines Affordable
    • Watch What Matters
  • Resources
  • News
  • Get Involved
  • About
    • Vision, Mission, Values
    • History
    • How We Work
    • Our Regions
    • Our Team
    • Our Board
  • Our Work
    • Treatment Education & Research
    • Intellectual Property & Access to Medicines
    • Community Monitoring
    • Building Activism
  • Our Campaigns
    • Be Healthy – Know Your Viral Load
    • Make Medicines Affordable
    • Watch What Matters
  • Resources
  • News
  • Get Involved
May 24, 2017  |  By ITPCglobal In Our Blog, Press

8 Things You Should Know About Preventing HIV

Solange Baptiste media TV appearance PrEP

Ahead of ITPC’s Global Think Tank Meeting on PrEP, ITPC Executive Director Solange Baptiste and Director of Global Programs & Advocacy Wame Mosime met with local media to increase awareness about PrEP and speak about ITPC’s work to ensure communities have a voice in processes around it. Information was also shared with media outlets in Port of Spain via a press release, supported by the United States President’s Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development’s (USAID) project Linkages across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES), and the M∙A∙C AIDS Fund.

Here are eight key takeaways – what you should know about preventing HIV:

1. What is HIV and AIDS?

HIV is the Human Immunodeficiency Virus, which causes HIV infection. Acquired Immune Deficiency Syndrome, or AIDS, is the most advanced stage of HIV infection.

2. How is HIV spread?

HIV is spread through unsafe contact with certain bodily fluids, such as rectal, vaginal, seminal and pre-seminal fluids, breast milk or blood. People who engage in unsafe contact with those fluids are at risk of contracting the virus.

3. Is HIV still a big problem?

There is a perception that HIV is no longer a problem, in part because recent advances in medical treatment have made it possible for people living with HIV to live a long and healthy life.

However, the harsh reality is very different:

  • Globally, there are close to 37,000,000 people living with HIV.
  • Every year since 2010, close to 2,000,000 adults have become newly infected with HIV.

4. Is there a cure for HIV?

In spite of decades of research leading to vast improvements in our knowledge, there is still no cure for HIV. However, HIV is no longer a death sentence. Treatment, through anti-retrovirals or ARVs, keeps the amount of virus in the blood low or suppressed, and people living with HIV who are diagnosed early and treated can have a long and healthy life.

5. Can HIV be prevented?

Because HIV is spread through unsafe contact with bodily fluids, it can be prevented through various methods such as abstinence, correct and consistent use of lubricants and condoms, use of sterile needles and, more recently, medicine.

6. What exactly is PrEP?

PrEP is a new and an additional preventive option for people who are HIV-negative but who are at high risk of infection. For PrEP you take a pill every day by mouth. If exposed to HIV and you are taking PrEP medicines daily, the high concentration of medicine in your blood will prevent infection. When used consistently, PrEP has been shown to reduce the risk of HIV infection among high-risk groups by up to 92 percent.

PrEP stands for Pre-Exposure Prophylaxis:

  • Pre = before
  • Exposure = coming into contact with HIV
  • Prophylaxis = treatment to prevent an infection from happening

PrEP is not just about a once-daily pill though; it is a comprehensive program that also includes:

  • Regular testing for HIV and other sexually transmitted infections
  • Regular testing for HIV and other sexually transmitted infections
  • Treatment of STIs
  • Regular counseling and adherence support
  • Education about the use condoms, lubrication and other prevention tools
  • Behavior interventions
  • Monitoring of side effects

7. What is the medical treatment for HIV?

People living with HIV take different combinations of medicines, called regimens, which control the amount of the virus in their body. A regimen works much like the lifelong treatment for a chronic disease such as diabetes or high blood pressure.

8. How does ITPC help people get access to treatment?

In an ideal world, everyone would have access to HIV testing, get medical treatment if needed, ensure their treatment is working, and have a voice on issues that affect their lives and health. But in reality, low levels of knowledge and other important factors continue to inhibit access to treatment including prevention methods such as the use of PrEP, particularly among marginalized groups such as sex workers, gay, bi-sexual, transgender people, people who use drugs and adolescents. Around the world, many community-based organizations are taking up the challenge to help increase access to PrEP for people who want it.

The International Treatment Preparedness Coalition (ITPC) is a worldwide coalition of people living with HIV and community advocates working to achieve universal access to optimal HIV treatment of those in need. Formed in 2003 by a group of 125 HIV activists from 65 countries at a meeting in Cape Town, South Africa, ITPC actively advocates for treatment access in eight regions across the globe. You can learn more about HIV in our Advocacy for Community Treatment (ACT) Toolkit

Previous StoryBTG Alliance drafts Declaration on the Right of People Who Use Drugs to Be Protected From State Sanctioned Violence
Next StoryITPC raises global awareness about new medicine for HIV prevention

Related Articles

  • jias cover photo
    Advocates Publish Commentary on Expanding Treatment Access for Viral Hepatitis C
  • differentiated service delivery
    Why Communities Must Be at the Center of Differentiated Service Delivery

no replies

Leave your comment Cancel Reply

(will not be shared)

Latest blog posts

  • jias cover photo
    Advocates Publish Commentary on Expanding Treatment Access for Viral Hepatitis C
  • differentiated service delivery
    Why Communities Must Be at the Center of Differentiated Service Delivery
  • ITPC 2018 PreConf Announcement-for website
    Save the Date: Join ITPC at the Community Activist Summit at AIDS 2018
  • PrEP training LATCA group photo
    How ITPC is Helping Countries Create Demand for PrEP
  • Wame Mosime FCAA 2017 domestic funding panel
    Civil Society Must Participate in Domestic Funding Dialogues – Here’s How

Archives

Categories

  • Commentaries
  • Latest News
  • Our Blog
  • Press

Sign up for our Newsletter

Keywords

access to medicines activists advocacy africa aids ARASA civil society communities community community system strengthening Community Treatment Observatory differentiated models of care dolutegravir DTG global fund HCV HIV HIV treatment human rights IAS ICASA India intellectual property ITPC ITPC MENA key population key populations make medicines affordable malawi Othoman Mellouk people living with HIV programs protest RCTO-WA rights routine viral load monitoring Solange Baptiste statement TB training treatment treatment education UN West Africa WHO

ABOUT US

  • Vision, Mission AND Values
  • HISTORY
  • HOW WE WORK
  • Our Team
  • Contact

OUR WORK

  • Treatment Education & ResearcH
  • Intellectual Property & Access to MedicincE
  • Health Financing & AccountabiliTY
  • Building ActivisM

CONNECT WITH ITPC

  • Great news from @DNDi!71 million people stand to benefit from reduced price treatment for #HepC!Read it here: https://t.co/paFOGXIzTR
    April 13, 2018
  • RT @JRatevosian: New @HealthGAP report on impact of HIV funding cuts to Mozambique, South Africa, Cameroon. It's deadly. More funding nee…
    April 11, 2018
  • Treatment advocates outline how we can use what we've learned from the #HIV examples to expand access to #HCV direc… https://t.co/AF3EDg4Il0
    April 11, 2018

Find us elsewhere

Copyright ©2017 ITPC